Sign inGet started

SNSE

Sensei Biotherapeutics, Inc.CIK 1829802 ☆ Sign in to watchCongress trades
Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
26

AI insights for SNSE PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
AI insights for SNSE
Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.
Upgrade to Pro · $99/yearAlready Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

InsiderRoleTradesBoughtSoldLast trade
Gerry ChristopherPresident & PEO1$0$02026-06-10
Holmen BobDirector8$0$02026-06-10
Donenberg Phillip B.Director3$0$02026-06-10
Peyer JamesDirector, 10% Owner89$4.16M$787.8K2026-06-01
Cambrian BioPharma Inc10% Owner89$4.16M$787.8K2026-06-01
Craver JosiahPrincipal Financial Officer3$0$02026-04-10
ICS OPPORTUNITIES II LLC10% Owner34$959.6K$627.5K2026-04-07
MILLENNIUM MANAGEMENT LLC10% Owner17$382.1K$77.0K2026-04-01
Parikh Anand KiranChief Operating Officer4$0$02026-02-19
Humer KristianDirector7$0$02025-05-21
RINGO WILLIAM RDirector7$0$02025-05-21
RICKS THOMAS GDirector12$249.6K$02025-05-21
van der Horst EdwardChief Scientific Officer10$0$02025-02-19
Celebi JohnPresident and CEO17$425$02025-02-19
Krebs StephanieChief Business Officer3$0$02025-02-14
English JessieDirector6$0$02024-06-11
Vojta DeneenDirector6$0$02024-06-11
Colgan ErinSVP of Finance13$0$02024-02-15
Broder SamuelDirector5$0$02023-07-10
Angermayer Christian10% Owner2$0$5.44M2023-06-01
Apeiron Investment Group Ltd.10% Owner2$3.5K$02023-02-23
Gallagher Patrick StephenChief Business Officer8$0$02023-02-15
Pierce Robert HamiltonChief Scientific Officer6$0$686.0K2022-02-15
SAMUELI SUSAN10% Owner2$0$02021-02-08
Fjaellskog Marie-LouiseChief Medical Officer1$0$02021-02-03
Hoey AnupamaChief Business Officer1$0$02021-02-03

Trade history

InsiderRoleCodeTradeFiledSharesPriceValueOwned after
Holmen BobDirector A Award deriv2026-06-102026-06-1212,500— $012,500SEC↗
Donenberg Phillip B.Director A Award deriv2026-06-102026-06-1212,500— $012,500SEC↗
Gerry ChristopherPresident & PEO A Award deriv2026-06-102026-06-12220,000— $0220,000SEC↗
Peyer James10% Owner S Sale2026-06-012026-06-01476$21.14 $10.1K130,142SEC↗
Peyer James10% Owner S Sale2026-06-012026-06-0124,524$20.00 $490.5K130,618SEC↗
Cambrian BioPharma Inc10% Owner S Sale2026-06-012026-06-01476$21.14 $10.1K130,142SEC↗
Cambrian BioPharma Inc10% Owner S Sale2026-06-012026-06-0124,524$20.00 $490.5K130,618SEC↗
Donenberg Phillip B.Director A Award deriv2026-04-102026-04-1423,100— $023,100SEC↗
Craver JosiahPFO & PAO A Award deriv2026-04-102026-04-1480,000— $080,000SEC↗
ICS OPPORTUNITIES II LLC10% Owner S Sale2026-04-072026-05-151,108$33.38 $37.0K133,986SEC↗
ICS OPPORTUNITIES II LLC10% Owner S Sale2026-04-072026-05-15300$32.25 $9.7K133,986SEC↗
ICS OPPORTUNITIES II LLC10% Owner S Sale2026-04-072026-05-154,423$31.38 $138.8K133,986SEC↗
ICS OPPORTUNITIES II LLC10% Owner S Sale2026-04-072026-05-15205$29.71 $6.1K133,986SEC↗
ICS OPPORTUNITIES II LLC10% Owner S Sale2026-04-072026-05-152,115$28.94 $61.2K133,986SEC↗
ICS OPPORTUNITIES II LLC10% Owner P Buy2026-04-072026-05-151,108$33.38 $37.0K133,986SEC↗
ICS OPPORTUNITIES II LLC10% Owner P Buy2026-04-062026-05-151,104$31.02 $34.2K141,029SEC↗
ICS OPPORTUNITIES II LLC10% Owner S Sale2026-04-062026-05-151,214$31.02 $37.7K141,029SEC↗
ICS OPPORTUNITIES II LLC10% Owner S Sale2026-04-062026-05-1545$31.96 $1.4K141,029SEC↗
ICS OPPORTUNITIES II LLC10% Owner P Buy2026-04-022026-05-15701$35.55 $24.9K144,974SEC↗
ICS OPPORTUNITIES II LLC10% Owner P Buy2026-04-022026-05-1526$33.47 $870144,974SEC↗
ICS OPPORTUNITIES II LLC10% Owner P Buy2026-04-022026-05-151,276$34.75 $44.3K144,974SEC↗
ICS OPPORTUNITIES II LLC10% Owner S Sale2026-04-022026-05-153,099$30.86 $95.6K144,974SEC↗
ICS OPPORTUNITIES II LLC10% Owner S Sale2026-04-022026-05-151,265$31.75 $40.2K144,974SEC↗
ICS OPPORTUNITIES II LLC10% Owner S Sale2026-04-022026-05-151,794$32.60 $58.5K144,974SEC↗
ICS OPPORTUNITIES II LLC10% Owner S Sale2026-04-022026-05-15374$33.35 $12.5K144,974SEC↗
ICS OPPORTUNITIES II LLC10% Owner S Sale2026-04-022026-05-151,134$34.80 $39.5K144,974SEC↗
MILLENNIUM MANAGEMENT LLC10% Owner P Buy2026-04-012026-05-153,401$35.46 $120.6K147,731SEC↗
MILLENNIUM MANAGEMENT LLC10% Owner S Sale2026-04-012026-05-151,104$31.52 $34.8K147,731SEC↗
MILLENNIUM MANAGEMENT LLC10% Owner S Sale2026-04-012026-05-1546$34.75 $1.6K147,731SEC↗
MILLENNIUM MANAGEMENT LLC10% Owner P Buy2026-04-012026-05-151,161$31.53 $36.6K147,731SEC↗
MILLENNIUM MANAGEMENT LLC10% Owner P Buy2026-04-012026-05-151,613$34.59 $55.8K147,731SEC↗
MILLENNIUM MANAGEMENT LLC10% Owner S Sale2026-03-312026-05-1587$31.52 $2.7K146,657SEC↗
MILLENNIUM MANAGEMENT LLC10% Owner S Sale2026-03-312026-05-155$28.41 $142146,657SEC↗
MILLENNIUM MANAGEMENT LLC10% Owner S Sale2026-03-312026-05-1557$27.11 $1.5K146,657SEC↗
MILLENNIUM MANAGEMENT LLC10% Owner S Sale2026-03-312026-05-151,251$25.17 $31.5K146,657SEC↗
MILLENNIUM MANAGEMENT LLC10% Owner S Sale2026-03-312026-05-15191$24.28 $4.6K146,657SEC↗
MILLENNIUM MANAGEMENT LLC10% Owner P Buy2026-03-312026-05-15411$32.60 $13.4K146,657SEC↗
MILLENNIUM MANAGEMENT LLC10% Owner P Buy2026-03-312026-05-151,957$31.45 $61.5K146,657SEC↗
MILLENNIUM MANAGEMENT LLC10% Owner P Buy2026-03-312026-05-1517$27.78 $472146,657SEC↗
MILLENNIUM MANAGEMENT LLC10% Owner P Buy2026-03-312026-05-151,048$26.73 $28.0K146,657SEC↗
MILLENNIUM MANAGEMENT LLC10% Owner P Buy2026-03-312026-05-151,770$25.32 $44.8K146,657SEC↗
MILLENNIUM MANAGEMENT LLC10% Owner P Buy2026-03-312026-05-15616$24.69 $15.2K146,657SEC↗
MILLENNIUM MANAGEMENT LLC10% Owner P Buy2026-03-312026-05-15186$30.48 $5.7K146,657SEC↗
ICS OPPORTUNITIES II LLC10% Owner P Buy2026-03-302026-05-15370$27.68 $10.2K145,678SEC↗
ICS OPPORTUNITIES II LLC10% Owner P Buy2026-03-302026-05-151,176$26.70 $31.4K145,678SEC↗
ICS OPPORTUNITIES II LLC10% Owner P Buy2026-03-302026-05-154,995$25.99 $129.8K145,678SEC↗
ICS OPPORTUNITIES II LLC10% Owner P Buy2026-03-302026-05-152,992$25.08 $75.0K145,678SEC↗
ICS OPPORTUNITIES II LLC10% Owner S Sale2026-03-302026-05-15370$27.68 $10.2K145,678SEC↗
ICS OPPORTUNITIES II LLC10% Owner S Sale2026-03-302026-05-15518$25.85 $13.4K145,678SEC↗
ICS OPPORTUNITIES II LLC10% Owner S Sale2026-03-272026-05-1536$27.37 $985142,360SEC↗
ICS OPPORTUNITIES II LLC10% Owner S Sale2026-03-272026-05-15469$26.77 $12.6K142,360SEC↗
ICS OPPORTUNITIES II LLC10% Owner P Buy2026-03-272026-05-15294$28.13 $8.3K142,360SEC↗
ICS OPPORTUNITIES II LLC10% Owner P Buy2026-03-272026-05-154,384$27.28 $119.6K142,360SEC↗
ICS OPPORTUNITIES II LLC10% Owner P Buy2026-03-272026-05-1510,643$26.29 $279.8K142,360SEC↗
ICS OPPORTUNITIES II LLC10% Owner P Buy2026-03-262026-05-15778$27.23 $21.2K131,370SEC↗
ICS OPPORTUNITIES II LLC10% Owner S Sale2026-03-262026-05-151,274$28.69 $36.6K131,370SEC↗
ICS OPPORTUNITIES II LLC10% Owner S Sale2026-03-262026-05-15583$26.88 $15.7K131,370SEC↗
ICS OPPORTUNITIES II LLC10% Owner P Buy2026-03-262026-05-151,025$29.98 $30.7K131,370SEC↗
ICS OPPORTUNITIES II LLC10% Owner P Buy2026-03-262026-05-152,601$28.85 $75.0K131,370SEC↗
ICS OPPORTUNITIES II LLC10% Owner P Buy2026-03-262026-05-151,327$27.95 $37.1K131,370SEC↗
Parikh Anand KiranChief Operating Officer A Award deriv2026-02-192026-02-191,239,305— $01,239,305SEC↗
Parikh Anand KiranChief Operating Officer A Award deriv2026-02-172026-02-1956,673— $056,673SEC↗
Parikh Anand KiranChief Operating Officer A Award deriv2026-02-172026-02-1992,533— $092,533SEC↗
Parikh Anand KiranChief Operating Officer A Award deriv2026-02-172026-02-19809,822— $0809,822SEC↗
Donenberg Phillip B.Director A Award deriv2026-02-132026-02-171,900— $01,900SEC↗
Peyer James10% Owner M Exercise deriv2025-12-092025-12-10395— $00SEC↗
Cambrian BioPharma Inc10% Owner M Exercise deriv2025-12-092025-12-10395— $00SEC↗
Peyer James10% Owner M Exercise2025-12-092025-12-10395$6.40 $2.5K155,983SEC↗
Peyer James10% Owner S Sale2025-12-092025-12-10446$7.92 $3.5K155,142SEC↗
Peyer James10% Owner S Sale2025-12-092025-12-102,666$7.95 $21.2K155,588SEC↗
Peyer James10% Owner S Sale2025-12-092025-12-10395$8.04 $3.2K155,588SEC↗
Cambrian BioPharma Inc10% Owner M Exercise2025-12-092025-12-10395$6.40 $2.5K155,983SEC↗
Cambrian BioPharma Inc10% Owner S Sale2025-12-092025-12-102,666$7.95 $21.2K155,588SEC↗
Cambrian BioPharma Inc10% Owner S Sale2025-12-092025-12-10395$8.04 $3.2K155,588SEC↗
Cambrian BioPharma Inc10% Owner S Sale2025-12-092025-12-10446$7.92 $3.5K155,142SEC↗
Cambrian BioPharma Inc10% Owner S Sale2025-12-092025-12-103,105$8.59 $26.7K158,254SEC↗
Peyer James10% Owner S Sale2025-12-082025-12-103,105$8.59 $26.7K158,254SEC↗
Peyer James10% Owner S Sale2025-12-052025-12-081,745$12.29 $21.4K161,401SEC↗
Peyer James10% Owner S Sale2025-12-052025-12-0842$13.16 $553161,359SEC↗
Peyer James10% Owner S Sale2025-12-052025-12-0814,508$11.40 $165.4K163,146SEC↗
Cambrian BioPharma Inc10% Owner S Sale2025-12-052025-12-081,745$12.29 $21.4K161,401SEC↗
Cambrian BioPharma Inc10% Owner S Sale2025-12-052025-12-0842$13.16 $553161,359SEC↗
Cambrian BioPharma Inc10% Owner S Sale2025-12-052025-12-0814,508$11.40 $165.4K163,146SEC↗
Peyer James10% Owner S Sale2025-12-042025-12-085,000$9.06 $45.3K177,654SEC↗
Cambrian BioPharma Inc10% Owner S Sale2025-12-042025-12-085,000$9.06 $45.3K177,654SEC↗
RINGO WILLIAM RDirector A Award deriv2025-05-212025-05-2319,000— $019,000SEC↗
Holmen BobDirector A Award deriv2025-05-212025-05-2319,000— $019,000SEC↗
Humer KristianDirector A Award deriv2025-05-212025-05-2319,000— $019,000SEC↗
Peyer JamesDirector, 10% Owner A Award deriv2025-05-212025-05-2319,000— $019,000SEC↗
RICKS THOMAS GDirector A Award deriv2025-05-212025-05-2319,000— $019,000SEC↗
Cambrian BioPharma Inc10% Owner A Award deriv2025-05-212025-05-2319,000— $019,000SEC↗
van der Horst EdwardCHIEF SCIENTIFIC OFFICER F Tax w/h2025-02-192025-02-262,276$0.48 $1.1K59,794SEC↗
Celebi JohnPRESIDENT AND CEO F Tax w/h2025-02-192025-02-265,558$0.48 $2.7K105,862SEC↗
van der Horst EdwardCHIEF SCIENTIFIC OFFICER A Award deriv2025-02-142025-02-14110,000— $0110,000SEC↗
Celebi JohnPRESIDENT AND CEO A Award deriv2025-02-142025-02-14360,000— $0360,000SEC↗
Craver JosiahPrincipal Financial Officer A Award deriv2025-02-142025-02-1450,000— $050,000SEC↗
Krebs StephanieChief Business Officer A Award deriv2025-02-142025-02-14120,000— $0120,000SEC↗
Celebi JohnPRESIDENT AND CEO A Award deriv2024-12-202024-12-23355,000— $0355,000SEC↗
Craver JosiahPrincipal Financial Officer A Award deriv2024-12-202024-12-23100,000— $0100,000SEC↗
van der Horst EdwardCHIEF SCIENTIFIC OFFICER A Award deriv2024-12-202024-12-23100,000— $0100,000SEC↗
Krebs StephanieChief Business Officer A Award deriv2024-12-202024-12-23120,000— $0120,000SEC↗
Vojta DeneenDirector A Award deriv2024-06-112024-06-1319,000— $019,000SEC↗
RICKS THOMAS GDirector A Award deriv2024-06-112024-06-1319,000— $019,000SEC↗
RINGO WILLIAM RDirector A Award deriv2024-06-112024-06-1319,000— $019,000SEC↗
Humer KristianDirector A Award deriv2024-06-112024-06-1319,000— $019,000SEC↗
English JessieDirector A Award deriv2024-06-112024-06-1319,000— $019,000SEC↗
Holmen BobDirector A Award deriv2024-06-112024-06-1319,000— $019,000SEC↗
Peyer JamesDirector, 10% Owner A Award deriv2024-06-112024-06-1319,000— $019,000SEC↗
Cambrian BioPharma Inc10% Owner A Award deriv2024-06-112024-06-1319,000— $019,000SEC↗
Colgan ErinCHIEF FINANCIAL OFFICER A Award deriv2024-02-152024-02-1694,128— $094,128SEC↗
Colgan ErinCHIEF FINANCIAL OFFICER A Award deriv2024-02-152024-02-16125,000— $0125,000SEC↗
Celebi JohnPRESIDENT AND CEO A Award deriv2024-02-152024-02-16165,889— $0165,889SEC↗
Celebi JohnPRESIDENT AND CEO A Award deriv2024-02-152024-02-16315,000— $0315,000SEC↗
van der Horst EdwardCHIEF SCIENTIFIC OFFICER A Award deriv2024-02-152024-02-1690,102— $090,102SEC↗
van der Horst EdwardCHIEF SCIENTIFIC OFFICER A Award deriv2024-02-152024-02-16125,000— $0125,000SEC↗
Colgan ErinCHIEF FINANCIAL OFFICER F Tax w/h2024-02-152024-02-163,627$0.79 $2.9K67,462SEC↗
Celebi JohnPRESIDENT AND CEO F Tax w/h2024-02-152024-02-165,891$0.79 $4.7K105,420SEC↗
van der Horst EdwardCHIEF SCIENTIFIC OFFICER F Tax w/h2024-02-152024-02-162,843$0.79 $2.2K56,070SEC↗
Krebs StephanieChief Business Officer A Award deriv2023-11-012023-11-02125,000— $0125,000SEC↗
Celebi JohnPresident and CEO P Buy2023-09-112023-09-13500$0.85 $425111,311SEC↗
Peyer JamesDirector, 10% Owner D To issuer2023-07-312023-08-021,587,302$1.26 $2.00M3,653,120SEC↗
Cambrian BioPharma Inc10% Owner D To issuer2023-07-312023-08-021,587,302$1.26 $2.00M3,653,120SEC↗
Cambrian BioPharma Inc10% Owner A Award deriv2023-07-102023-07-1214,550— $014,550SEC↗
Peyer JamesDirector, 10% Owner A Award deriv2023-07-102023-07-1214,550— $014,550SEC↗
Holmen BobDirector A Award deriv2023-07-102023-07-1214,550— $014,550SEC↗
Vojta DeneenDirector A Award deriv2023-07-102023-07-1214,550— $014,550SEC↗
English JessieDirector A Award deriv2023-07-102023-07-1214,550— $014,550SEC↗
Humer KristianDirector A Award deriv2023-07-102023-07-1214,550— $014,550SEC↗
Broder SamuelDirector A Award deriv2023-07-102023-07-1214,550— $014,550SEC↗
RICKS THOMAS GDirector A Award deriv2023-07-102023-07-1214,550— $014,550SEC↗
RINGO WILLIAM RDirector A Award deriv2023-07-102023-07-1214,550— $014,550SEC↗
Cambrian BioPharma Inc10% Owner A Award2023-07-102023-07-124,466— $05,240,422SEC↗
Peyer JamesDirector, 10% Owner A Award2023-07-102023-07-124,466— $05,240,422SEC↗
Holmen BobDirector A Award2023-07-102023-07-124,466— $025,598SEC↗
Vojta DeneenDirector A Award2023-07-102023-07-124,466— $08,932SEC↗
English JessieDirector A Award2023-07-102023-07-124,466— $08,932SEC↗
Humer KristianDirector A Award2023-07-102023-07-124,466— $08,932SEC↗
Broder SamuelDirector A Award2023-07-102023-07-124,466— $08,932SEC↗
RICKS THOMAS GDirector A Award2023-07-102023-07-124,466— $08,932SEC↗
RINGO WILLIAM RDirector A Award2023-07-102023-07-124,466— $023,399SEC↗
Angermayer Christian10% Owner S Sale2023-06-012023-06-022,485,923$1.58 $3.93M0SEC↗
Angermayer Christian10% Owner S Sale2023-06-012023-06-02955,738$1.58 $1.51M0SEC↗
Apeiron Investment Group Ltd.10% Owner P Buy2023-02-232023-02-271,100$1.60 $1.8K2,485,923SEC↗
Apeiron Investment Group Ltd.10% Owner P Buy2023-02-232023-02-271,100$1.62 $1.8K2,484,823SEC↗
Colgan ErinChief Financial Officer F Tax w/h2023-02-152023-09-1110,943$1.50 $16.4K68,089SEC↗
Celebi JohnPresident and CEO F Tax w/h2023-02-152023-09-1120,492$1.50 $30.7K110,811SEC↗
van der Horst EdwardChief Scientific Officer F Tax w/h2023-02-152023-09-119,525$1.50 $14.3K52,913SEC↗
Gallagher Patrick StephenChief Business Officer F Tax w/h2023-02-152023-09-119,383$1.50 $14.1K34,130SEC↗
Celebi JohnPresident and CEO A Award deriv2023-02-152023-02-1790,000— $090,000SEC↗
Gallagher Patrick StephenChief Business Officer A Award deriv2023-02-152023-02-1760,000— $060,000SEC↗
Colgan ErinChief Financial Officer A Award deriv2023-02-152023-02-1790,000— $090,000SEC↗
van der Horst EdwardChief Scientific Officer A Award deriv2023-02-152023-02-1775,000— $075,000SEC↗
Gallagher Patrick StephenChief Business Officer A Award deriv2023-02-152023-03-2960,000— $060,000SEC↗
Celebi JohnPresident and CEO A Award deriv2023-02-152023-03-2990,000— $090,000SEC↗
Colgan ErinChief Financial Officer A Award deriv2023-02-152023-03-2990,000— $090,000SEC↗
Celebi JohnPresident and CEO A Award2023-02-152023-02-1751,893— $0106,007SEC↗
Celebi JohnPresident and CEO A Award2023-02-152023-02-1721,300— $0127,307SEC↗
Gallagher Patrick StephenChief Business Officer A Award2023-02-152023-02-1714,200— $043,515SEC↗
Gallagher Patrick StephenChief Business Officer A Award2023-02-152023-02-1729,313— $029,313SEC↗
Colgan ErinChief Financial Officer A Award2023-02-152023-02-1721,300— $073,032SEC↗
Colgan ErinChief Financial Officer A Award2023-02-152023-02-1730,046— $051,732SEC↗
van der Horst EdwardChief Scientific Officer A Award2023-02-152023-02-1717,700— $062,438SEC↗
van der Horst EdwardChief Scientific Officer A Award2023-02-152023-02-1723,565— $044,738SEC↗
Gallagher Patrick StephenChief Business Officer A Award2023-02-152023-03-2929,313— $029,313SEC↗
Gallagher Patrick StephenChief Business Officer A Award2023-02-152023-03-2914,200— $043,513SEC↗
Celebi JohnPresident and CEO A Award2023-02-152023-03-2951,893— $0110,003SEC↗
Celebi JohnPresident and CEO A Award2023-02-152023-03-2921,300— $0131,303SEC↗
Colgan ErinChief Financial Officer A Award2023-02-152023-03-2930,046— $057,732SEC↗
Colgan ErinChief Financial Officer A Award2023-02-152023-03-2921,300— $079,032SEC↗
Cambrian BioPharma Inc10% Owner A Award deriv2022-06-102023-03-0714,550— $014,550SEC↗
Cambrian BioPharma Inc10% Owner A Award2022-06-102023-03-074,466— $05,235,956SEC↗
Peyer JamesDirector, 10% Owner A Award deriv2022-06-102022-08-0114,550— $014,550SEC↗
Peyer JamesDirector, 10% Owner A Award2022-06-102022-08-014,466— $05,235,956SEC↗
Holmen BobDirector A Award deriv2022-06-102022-06-1414,550— $014,550SEC↗
Broder SamuelDirector A Award deriv2022-06-102022-06-1414,550— $014,550SEC↗
Humer KristianDirector A Award deriv2022-06-102022-06-1414,550— $014,550SEC↗
RICKS THOMAS GDirector A Award deriv2022-06-102022-06-1414,550— $014,550SEC↗
English JessieDirector A Award deriv2022-06-102022-06-1414,550— $014,550SEC↗
Vojta DeneenDirector A Award deriv2022-06-102022-06-1414,550— $014,550SEC↗
Peyer JamesDirector, 10% Owner A Award deriv2022-06-102022-06-1414,550— $014,550SEC↗
Cambrian BioPharma Inc10% Owner A Award deriv2022-06-102022-06-1414,550— $014,550SEC↗
Holmen BobDirector A Award2022-06-102022-06-144,466— $021,132SEC↗
Broder SamuelDirector A Award2022-06-102022-06-144,466— $04,466SEC↗
Humer KristianDirector A Award2022-06-102022-06-144,466— $04,466SEC↗
RICKS THOMAS GDirector A Award2022-06-102022-06-144,466— $04,466SEC↗
English JessieDirector A Award2022-06-102022-06-144,466— $04,466SEC↗
Vojta DeneenDirector A Award2022-06-102022-06-144,466— $04,466SEC↗
Peyer JamesDirector, 10% Owner A Award2022-06-102022-06-144,466— $05,235,954SEC↗
Cambrian BioPharma Inc10% Owner A Award2022-06-102022-06-144,466— $05,235,954SEC↗
Gallagher Patrick StephenChief Business Officer A Award deriv2022-06-012022-06-03150,000— $0150,000SEC↗
RINGO WILLIAM RDirector A Award deriv2022-03-082022-03-0929,100— $029,100SEC↗
RINGO WILLIAM RDirector A Award2022-03-082022-03-0910,000— $018,933SEC↗
RINGO WILLIAM RDirector A Award2022-03-082022-03-098,933— $08,933SEC↗
Cambrian BioPharma Inc10% Owner P Buy2022-03-022022-06-101,203$3.20 $3.8K5,231,488SEC↗
Peyer JamesDirector, 10% Owner P Buy2022-03-022022-06-101,203$3.20 $3.8K5,231,488SEC↗
Peyer JamesDirector, 10% Owner P Buy2022-03-022022-03-021,203$3.20 $3.8K5,231,989SEC↗
Cambrian BioPharma Inc10% Owner P Buy2022-03-022022-03-021,203$3.20 $3.8K5,231,989SEC↗
Cambrian BioPharma Inc10% Owner P Buy2022-03-012022-03-012,458$3.60 $8.8K5,230,786SEC↗
Peyer JamesDirector, 10% Owner P Buy2022-03-012022-03-012,458$3.60 $8.8K5,230,786SEC↗
Cambrian BioPharma Inc10% Owner P Buy2022-02-282022-03-0142$3.60 $1515,228,328SEC↗
Peyer JamesDirector, 10% Owner P Buy2022-02-282022-03-0142$3.60 $1515,228,328SEC↗
Cambrian BioPharma Inc10% Owner P Buy2022-02-252022-02-282,500$3.65 $9.1K5,228,286SEC↗
Peyer JamesDirector, 10% Owner P Buy2022-02-252022-02-282,500$3.65 $9.1K5,228,286SEC↗
Peyer JamesDirector, 10% Owner P Buy2022-02-242022-02-2415,000$3.63 $54.5K5,225,786SEC↗
Cambrian BioPharma Inc10% Owner P Buy2022-02-242022-02-2415,000$3.63 $54.5K5,225,786SEC↗
Peyer JamesDirector, 10% Owner P Buy2022-02-232022-02-242,500$3.80 $9.5K5,210,786SEC↗
Cambrian BioPharma Inc10% Owner P Buy2022-02-232022-02-242,500$3.80 $9.5K5,210,786SEC↗
Cambrian BioPharma Inc10% Owner P Buy2022-02-182022-02-2215,000$3.97 $59.5K5,208,286SEC↗
Peyer JamesDirector, 10% Owner P Buy2022-02-182022-02-2215,000$3.97 $59.5K5,208,286SEC↗
Cambrian BioPharma Inc10% Owner P Buy2022-02-172022-02-224,949$4.17 $20.6K5,193,286SEC↗
Peyer JamesDirector, 10% Owner P Buy2022-02-172022-02-224,949$4.17 $20.6K5,193,286SEC↗
Peyer JamesDirector, 10% Owner P Buy2022-02-162022-02-162,551$4.25 $10.8K5,188,337SEC↗
Cambrian BioPharma Inc10% Owner P Buy2022-02-162022-02-162,551$4.25 $10.8K5,188,337SEC↗
Celebi JohnPresident and CEO A Award deriv2022-02-152022-02-17161,600— $0161,600SEC↗
Colgan ErinChief Financial Officer A Award deriv2022-02-152022-02-1762,000— $062,000SEC↗
Pierce Robert HamiltonChief R&D Officer A Award deriv2022-02-152022-02-1762,000— $062,000SEC↗
Celebi JohnPresident and CEO A Award2022-02-152022-02-1753,900— $054,114SEC↗
Colgan ErinChief Financial Officer A Award2022-02-152022-02-1721,000— $021,686SEC↗
Pierce Robert HamiltonChief R&D Officer A Award2022-02-152022-02-1721,000— $021,000SEC↗
Peyer JamesDirector, 10% Owner P Buy2022-02-142022-02-1610,000$4.18 $41.8K5,185,786SEC↗
Cambrian BioPharma Inc10% Owner P Buy2022-02-142022-02-1610,000$4.18 $41.8K5,185,786SEC↗
Cambrian BioPharma Inc10% Owner P Buy2022-02-112022-02-1412,500$4.40 $55.0K5,175,786SEC↗
Peyer JamesDirector, 10% Owner P Buy2022-02-112022-02-1412,500$4.40 $55.0K5,175,786SEC↗
Cambrian BioPharma Inc10% Owner P Buy2022-02-102022-02-145,000$4.58 $22.9K5,163,286SEC↗
Peyer JamesDirector, 10% Owner P Buy2022-02-102022-02-145,000$4.58 $22.9K5,163,286SEC↗
Peyer JamesDirector, 10% Owner P Buy2022-02-082022-02-0810,000$4.33 $43.3K5,158,286SEC↗
Cambrian BioPharma Inc10% Owner P Buy2022-02-082022-02-0810,000$4.33 $43.3K5,158,286SEC↗
Peyer JamesDirector, 10% Owner P Buy2022-02-042022-02-082,500$4.45 $11.1K5,148,286SEC↗
Cambrian BioPharma Inc10% Owner P Buy2022-02-042022-02-082,500$4.45 $11.1K5,148,286SEC↗
Peyer JamesDirector, 10% Owner P Buy2022-02-032022-02-0817,500$4.65 $81.4K5,145,786SEC↗
Cambrian BioPharma Inc10% Owner P Buy2022-02-032022-02-0817,500$4.65 $81.4K5,145,786SEC↗
Peyer JamesDirector, 10% Owner P Buy2022-01-282022-01-318,900$4.22 $37.6K5,128,286SEC↗
Cambrian BioPharma Inc10% Owner P Buy2022-01-282022-01-318,900$4.22 $37.6K5,128,286SEC↗
Peyer JamesDirector, 10% Owner P Buy2022-01-272022-01-316,100$4.31 $26.3K5,119,386SEC↗
Cambrian BioPharma Inc10% Owner P Buy2022-01-272022-01-316,100$4.31 $26.3K5,119,386SEC↗
Cambrian BioPharma Inc10% Owner P Buy2022-01-262022-01-2729,900$4.62 $138.1K5,113,286SEC↗
Peyer JamesDirector, 10% Owner P Buy2022-01-262022-01-2729,900$4.62 $138.1K5,113,286SEC↗
Cambrian BioPharma Inc10% Owner P Buy2022-01-252022-01-2720,100$4.86 $97.7K5,083,386SEC↗
Peyer JamesDirector, 10% Owner P Buy2022-01-252022-01-2720,100$4.86 $97.7K5,083,386SEC↗
Cambrian BioPharma Inc10% Owner P Buy2022-01-242022-01-2522,707$4.69 $106.5K5,063,286SEC↗
Peyer JamesDirector, 10% Owner P Buy2022-01-242022-01-2522,707$4.69 $106.5K5,063,286SEC↗
Cambrian BioPharma Inc10% Owner P Buy2022-01-212022-01-2524,703$4.94 $122.0K5,040,579SEC↗
Peyer JamesDirector, 10% Owner P Buy2022-01-212022-01-2524,703$4.94 $122.0K5,040,579SEC↗
Cambrian BioPharma Inc10% Owner P Buy2022-01-202022-01-2120,000$5.17 $103.4K5,015,876SEC↗
Peyer JamesDirector, 10% Owner P Buy2022-01-202022-01-2120,000$5.17 $103.4K5,015,876SEC↗
Cambrian BioPharma Inc10% Owner P Buy2022-01-192022-01-2110,244$4.97 $50.9K4,995,876SEC↗
Peyer JamesDirector, 10% Owner P Buy2022-01-192022-01-2110,244$4.97 $50.9K4,995,876SEC↗
Cambrian BioPharma Inc10% Owner P Buy2022-01-182022-01-2010,000$5.08 $50.8K4,985,632SEC↗
Peyer JamesDirector, 10% Owner P Buy2022-01-182022-01-2010,000$5.08 $50.8K4,985,632SEC↗
Cambrian BioPharma Inc10% Owner P Buy2022-01-142022-01-186,219$4.99 $31.0K4,975,632SEC↗
Peyer JamesDirector, 10% Owner P Buy2022-01-142022-01-186,219$4.99 $31.0K4,975,632SEC↗
Cambrian BioPharma Inc10% Owner P Buy2022-01-132022-01-1819,953$5.13 $102.4K4,969,413SEC↗
Peyer JamesDirector, 10% Owner P Buy2022-01-132022-01-1819,953$5.13 $102.4K4,969,413SEC↗
Cambrian BioPharma Inc10% Owner P Buy2022-01-122022-01-139,202$5.22 $48.0K4,949,460SEC↗
Peyer JamesDirector, 10% Owner P Buy2022-01-122022-01-139,202$5.22 $48.0K4,949,460SEC↗
Cambrian BioPharma Inc10% Owner P Buy2022-01-112022-01-1310,845$5.18 $56.2K4,940,258SEC↗
Peyer JamesDirector, 10% Owner P Buy2022-01-112022-01-1310,845$5.18 $56.2K4,940,258SEC↗
Cambrian BioPharma Inc10% Owner P Buy2022-01-102022-01-1110,000$5.28 $52.8K4,929,413SEC↗
Peyer JamesDirector, 10% Owner P Buy2022-01-102022-01-1110,000$5.28 $52.8K4,929,413SEC↗
10% Owner P Buy2021-12-302022-01-031,127$4.85 $5.5K4,919,413SEC↗
Peyer JamesDirector, 10% Owner P Buy2021-12-302022-01-031,127$4.85 $5.5K4,919,413SEC↗
Cambrian BioPharma Inc10% Owner P Buy2021-12-292021-12-3069,000$4.98 $343.6K4,918,286SEC↗
Peyer JamesDirector, 10% Owner P Buy2021-12-292021-12-3069,000$4.98 $343.6K4,918,286SEC↗
Cambrian BioPharma Inc10% Owner P Buy2021-12-282021-12-2911,288$5.28 $59.6K4,849,286SEC↗
Peyer JamesDirector, 10% Owner P Buy2021-12-282021-12-2911,288$5.28 $59.6K4,849,286SEC↗
Cambrian BioPharma Inc10% Owner P Buy2021-12-272021-12-273,712$5.30 $19.7K4,837,998SEC↗
Peyer JamesDirector, 10% Owner P Buy2021-12-272021-12-273,712$5.30 $19.7K4,837,998SEC↗
Cambrian BioPharma Inc10% Owner P Buy2021-12-232021-12-2311,000$5.27 $58.0K4,834,286SEC↗
Peyer JamesDirector, 10% Owner P Buy2021-12-232021-12-2311,000$5.27 $58.0K4,834,286SEC↗
Cambrian BioPharma Inc10% Owner P Buy2021-12-172021-12-21117$5.29 $6194,823,286SEC↗
Peyer JamesDirector, 10% Owner P Buy2021-12-172021-12-21117$5.29 $6194,823,286SEC↗
Peyer JamesDirector, 10% Owner P Buy2021-12-162021-12-2010,925$5.25 $57.4K4,823,169SEC↗
Cambrian BioPharma Inc10% Owner P Buy2021-12-162021-12-2010,925$5.25 $57.4K4,823,169SEC↗
RICKS THOMAS GDirector P Buy2021-12-102021-12-1320,000$5.86 $117.2K341,769SEC↗
RICKS THOMAS GDirector P Buy2021-12-092021-12-1320,000$6.62 $132.4K321,769SEC↗
Pierce Robert HamiltonChief Scientific Officer S Sale2021-08-112021-08-1216,030$7.34 $117.7K0SEC↗
Pierce Robert HamiltonChief Scientific Officer S Sale2021-08-102021-08-1066,350$7.13 $473.1K16,030SEC↗
Pierce Robert HamiltonChief Scientific Officer S Sale2021-08-092021-08-106,982$7.06 $49.3K82,380SEC↗
Pierce Robert HamiltonChief Scientific Officer S Sale2021-08-062021-08-106,460$7.11 $45.9K89,362SEC↗
Humer KristianDirector A Award deriv2021-07-302021-08-0216,667— $016,667SEC↗
Peyer JamesDirector, 10% Owner P Buy2021-05-052021-05-06350$12.00 $4.2K4,812,244SEC↗
Cambrian BioPharma Inc10% Owner P Buy2021-05-052021-05-06350$12.00 $4.2K4,812,244SEC↗
Peyer JamesDirector, 10% Owner P Buy2021-04-202021-04-21385$12.77 $4.9K4,811,894SEC↗
Cambrian BioPharma Inc10% Owner P Buy2021-04-202021-04-21385$12.77 $4.9K4,811,894SEC↗
Cambrian BioPharma Inc10% Owner P Buy2021-04-192021-04-201,965$13.38 $26.3K4,811,509SEC↗
Peyer JamesDirector, 10% Owner P Buy2021-04-192021-04-201,965$13.38 $26.3K4,811,509SEC↗
Peyer JamesDirector, 10% Owner P Buy2021-04-132021-04-142,000$14.00 $28.0K4,809,544SEC↗
Cambrian BioPharma Inc10% Owner P Buy2021-04-132021-04-142,000$14.00 $28.0K4,809,544SEC↗
Cambrian BioPharma Inc10% Owner P Buy2021-04-072021-04-082,000$14.00 $28.0K4,807,544SEC↗
Peyer JamesDirector, 10% Owner P Buy2021-04-072021-04-082,000$14.00 $28.0K4,807,544SEC↗
English JessieDirector A Award deriv2021-04-012021-04-0516,667— $016,667SEC↗
Peyer JamesDirector, 10% Owner P Buy2021-04-012021-04-021,000$14.00 $14.0K4,805,544SEC↗
Cambrian BioPharma Inc10% Owner P Buy2021-04-012021-04-021,000$14.00 $14.0K4,805,544SEC↗
Peyer JamesDirector, 10% Owner P Buy2021-03-302021-03-312,000$12.00 $24.0K4,804,544SEC↗
Cambrian BioPharma Inc10% Owner P Buy2021-03-302021-03-312,000$12.00 $24.0K4,804,544SEC↗
Cambrian BioPharma Inc10% Owner P Buy2021-03-242021-03-253,750$14.12 $53.0K4,802,544SEC↗
Peyer JamesDirector, 10% Owner P Buy2021-03-242021-03-253,750$14.12 $53.0K4,802,544SEC↗
Cambrian BioPharma Inc10% Owner P Buy2021-03-232022-04-219,500$14.34 $136.2K4,798,293SEC↗
Peyer JamesDirector, 10% Owner P Buy2021-03-232022-04-219,500$14.34 $136.2K4,798,293SEC↗
Cambrian BioPharma Inc10% Owner P Buy2021-03-232021-03-2410,000$14.34 $143.4K4,798,794SEC↗